NewsRx

Search our medical news database

Biomedical Engineering

Haemacure Reports First Quarter 2007 Results

Published in Healthcare Mergers, Acquisitions and Ventures Week, March 24th, 2007

Haemacure Corporation (TSX:HAE) released today the results of its first quarter ended January 31, 2007.

Results

Revenues amounted to $32,106, as compared to $48,062 for the same quarter last year. Revenues are exclusively derived from the sale of fibrin sealant application devices, HemaSyst(TM)and HemaMyst(TM). Operating expenses amounted to $828,482, as compared to $880,363 for the same quarter last year. The decrease is mainly attributed to a decrease in general and administrative expenses. The consolidated net loss for the quarter amounted to $813,253, or $0.01 per share, as compared to $851,895, or $0.02 per share, for the same quarter last...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook